During the past decade, Policlinico Tor Vergata; Divisione Di Reumatologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Policlinico Tor Vergata; Divisione Di Reumatologia" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Policlinico Tor Vergata; Divisione Di Reumatologia" in a lesser frequency.

Most popular intervention types in "Policlinico Tor Vergata; Divisione Di Reumatologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DMARDs" (1 trials), "Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)" (1 trials), "Tocilizumab" (1 trials) and "tocilizumab [RoActemra/Actemra]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Tor Vergata; Divisione Di Reumatologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Tor Vergata; Divisione Di Reumatologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Policlinico Tor Vergata; Divisione Di Reumatologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Tor Vergata; Divisione Di Reumatologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".